Athanasio Bruno da Silva, Andrade Antonio Marcio de Faria, Costa Vivian Vasconcelos, Castro Juliano Felix, Garcia Silverio Leonardo Macedo, Teixeira Mauro Martins, Souza Daniele da Gloria, Vidigal Paula Vieira Teixeira, Lima Cristiano Xavier
Department of Surgery, Federal University of Minas Gerais, Belo Horizonte 30130-100, Minas Gerais, Brazil.
Liver Transplantation Unit, Felicio Rocho Hospital, Belo Horizonte 30110-934, Minas Gerais, Brazil.
World J Transplant. 2025 Mar 18;15(1):100413. doi: 10.5500/wjt.v15.i1.100413.
Acute liver failure (ALF) is a severe condition characterized by rapid deterioration of liver function in individuals without preexisting liver disease. Liver transplantation (LT) is the most impactful treatment. Yellow fever (YF) is an infectious disease that primarily affects the liver and has a high mortality rate. However, LT can be a viable option for treating rare cases with extensive liver involvement. However, the criteria for assessing the severity of ALF and determining the indications for transplantation have not been specifically validated for cases caused by YF.
To present necessary adjustments to established scoring systems for ALF secondary to YF.
This was an observational, retrospective, single-center study. Fourteen consecutive patients with confirmed ALF due to YF were monitored in the intensive care unit by a specialized liver transplant team during a three-month epidemic outbreak in Brazil. During hospitalization, general supportive therapeutic measures were implemented, and the patients were regularly assessed using the King's College criteria and the Clichy-Villejuif criteria to determine the severity of liver failure. LT is considered a viable measure for patients with signs of end-stage liver failure.
Eight of 14 (57%) patients developed severe neurological alterations within the first 96 hours after hospital admission. Four patients underwent emergency LT, and despite a moderate viral infection of the graft after transplantation, the 5-year survival rate was 50%. Although the King's College criteria and the Clichy-Villejuif criteria are the main scoring systems for ALF, they are insufficient for predicting the risk of mortality in this context, primarily because of low serum bilirubin levels in the final stage of the disease and significant disparities between coagulation abnormalities and patient severity.
To ensure good applicability in cases of YF-induced ALF, the authors suggest adaptations to the King's College and Clichy-Villejuif criteria.
急性肝衰竭(ALF)是一种严重病症,其特征为既往无肝病的个体肝功能迅速恶化。肝移植(LT)是最具影响力的治疗方法。黄热病(YF)是一种主要影响肝脏且死亡率高的传染病。然而,对于罕见的广泛肝脏受累病例,肝移植可能是一种可行的选择。然而,评估急性肝衰竭严重程度和确定移植指征的标准尚未在黄热病所致病例中得到专门验证。
针对黄热病继发的急性肝衰竭,对既定评分系统提出必要调整。
这是一项观察性、回顾性、单中心研究。在巴西为期三个月的疫情爆发期间,一个专业的肝移植团队在重症监护病房对14例确诊为黄热病所致急性肝衰竭的连续患者进行了监测。住院期间,实施了一般支持性治疗措施,并定期使用国王学院标准和克利希 - 维勒瑞夫标准对患者进行评估,以确定肝衰竭的严重程度。对于出现终末期肝衰竭迹象的患者,肝移植被视为一种可行的措施。
14例患者中有8例(57%)在入院后的头96小时内出现严重神经功能改变。4例患者接受了急诊肝移植,尽管移植后移植物有中度病毒感染,但5年生存率为50%。尽管国王学院标准和克利希 - 维勒瑞夫标准是急性肝衰竭的主要评分系统,但它们不足以预测这种情况下的死亡风险,主要原因是疾病末期血清胆红素水平较低以及凝血异常与患者严重程度之间存在显著差异。
为确保在黄热病诱发的急性肝衰竭病例中具有良好的适用性,作者建议对国王学院标准和克利希 - 维勒瑞夫标准进行调整。